Artificial Intelligence in Diagnostics Market, By Component (Software, Hardware, and Services), By Diagnosis, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Artificial Intelligence in Diagnostics Market size was valued at USD 1,567.12 Million in 2024, expanding at a CAGR of 22.5% from 2024 to 2032.
Artificial Intelligence in diagnostics refers to the application of advanced algorithms and machine learning techniques to analyze medical data and assist in the detection of diseases or conditions. By processing large volumes of clinical information, medical imaging, and patient history, AI systems can identify patterns and anomalies that may be difficult for human clinicians to detect. This technology enhances diagnostic accuracy, accelerates decision-making, and supports healthcare professionals in delivering more informed and effective care. AI-powered diagnostics play a crucial role in early disease detection, personalized treatment planning, and improved patient outcomes, while also reducing medical errors and healthcare costs. As a result, AI is emerging as a transformative force in modern medicine, bridging the gap between data science and clinical expertise.
Artificial Intelligence in Diagnostics Market- Market Dynamics
Growing Demand for Early and Precise Disease Detection
The increasing focus on early and accurate diagnosis is a key driver of the AI in diagnostics market. Healthcare systems worldwide are prioritizing timely disease detection to improve patient outcomes and reduce overall treatment costs. Artificial Intelligence enhances diagnostic precision by rapidly analyzing complex datasets, including medical imaging, genetic information, and electronic health records. This capability is especially valuable for the early detection of conditions such as cancer, cardiovascular diseases, and neurological disorders. Consequently, hospitals, clinics, and diagnostic laboratories are increasingly adopting AI-powered tools to reduce diagnostic errors, speed up the diagnostic process, and support personalized treatment planning.
Government initiatives further reinforce this trend. For example, the U.S. government’s National AI Initiative Act promotes the integration of AI in healthcare to enhance diagnostics and patient care, while the European Union has invested over €1 billion in AI healthcare projects under its Horizon Europe program. Additionally, countries like China and India are launching national AI strategies focusing on improving healthcare diagnostics to expand access and efficiency globally. These efforts highlight a strong global commitment to leveraging AI for early and accurate disease detection.
Artificial Intelligence in Diagnostics Market- Segmentation Analysis:
The global Artificial Intelligence in Diagnostics Market is divided into Three categories: Component, Diagnosis, and Region.
The Artificial Intelligence in Diagnostics market is segmented by component into software, hardware, and services, with software emerging as the dominant segment. This dominance is driven by software’s central role in processing data, executing complex algorithms, and generating accurate diagnostic outputs. AI-powered software solutions are crucial for interpreting medical images, analyzing laboratory results, and supporting clinical decision-making processes. These platforms continuously improve through machine learning, enhancing diagnostic accuracy and adapting to increasingly complex medical challenges. According to a 2024 report by the U.S. Food and Drug Administration (FDA), the number of AI-based software devices cleared for diagnostic use has increased by over 35% in the past two years, highlighting growing regulatory acceptance and market adoption. The integration of AI software with hospital systems, electronic health records (EHRs), and imaging equipment further strengthens its market leadership. Additionally, software solutions offer scalability, remote accessibility, and cost-efficiency, making them more attractive to healthcare providers compared to hardware and services, which often require higher upfront investments and extensive infrastructure support.
In terms of diagnosis segments, the Artificial Intelligence in Diagnostics market is divided into cardiology, oncology, pathology, radiology, chest and lung, neurology, and others, with radiology holding the largest market share. This prominence stems from the vast volume of imaging data generated in radiology and the critical need for precise interpretation. AI technologies are transforming radiology by enhancing the analysis of X-rays, MRIs, CT scans, and ultrasounds, enabling faster and more accurate detection of abnormalities such as tumors, fractures, and internal bleeding. The ability of AI algorithms to identify subtle patterns and reduce diagnostic errors has made them invaluable tools for radiologists. The Centers for Medicare & Medicaid Services (CMS) reported a 25% increase in AI-assisted imaging procedures reimbursed between 2022 and 2024, reflecting the rising demand for AI in imaging diagnostics. This trend is especially pronounced in chronic disease management and emergency care, where timely and accurate imaging is crucial, thus reinforcing AI’s dominant position in the radiology segment.
Artificial Intelligence in Diagnostics Market- Geographical Insights
The Artificial Intelligence in Diagnostics Market is geographically distributed across North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa, with further segmentation based on key contributing countries within these regions.
North America leads the AI in diagnostics market, largely driven by the United States. The region benefits from a well-established healthcare infrastructure, substantial investments in AI technologies, and strong government support. Collaboration between leading technology companies, startups, and healthcare providers is fostering the development of advanced diagnostic tools, particularly in fields like radiology and oncology. High adoption rates of electronic health records (EHRs), a growing prevalence of chronic diseases, and increasing demand for precision medicine are further fueling market growth. Regulatory agencies such as the FDA actively approve AI-based diagnostic solutions, enhancing trust and accelerating clinical adoption. For instance, the U.S. government’s National AI Initiative Act allocates significant funding to advance AI applications in healthcare, supporting innovation and adoption. These factors collectively position North America as a global leader in AI-driven diagnostic innovation.
Asia Pacific is rapidly emerging as a key growth market, led by countries including China, Japan, and India. The region is experiencing swift digital transformation in healthcare, rising investments in AI startups, and growing government initiatives focused on health technology innovation. High patient volumes and increasing rates of chronic diseases are driving demand for scalable and efficient diagnostic solutions. Government strategies, such as China’s national AI development plan and India’s National Digital Health Mission, are strengthening the ecosystem and expanding healthcare access. Additionally, the European Union’s Horizon Europe program has invested over €1 billion in AI healthcare projects to enhance diagnostics and patient care. Partnerships between local healthcare institutions and global technology firms are accelerating AI adoption, establishing Asia Pacific as one of the most dynamic and fast-growing markets in the AI diagnostics sector.
Artificial Intelligence in Diagnostics Market- Competitive Landscape:
The competitive landscape of the Artificial Intelligence in Diagnostics market is shaped by a blend of established healthcare and med-tech giants alongside innovative startups driving technological advancements. Leading companies such as Siemens Healthineers, GE Healthcare, Aidoc, and Digital Diagnostics, Inc. dominate the market with robust AI platforms focused on medical imaging, cardiology, and pathology. These industry leaders emphasize significant investments in research and development, strict regulatory compliance, and strategic partnerships to broaden their AI capabilities. At the same time, emerging players like Vuno, Inc. and NovaSignal Corporation are introducing disruptive solutions, particularly in neurology and real-time data analysis. This dynamic mix fosters continuous innovation, wider AI adoption in diagnostics, and improved clinical decision support for healthcare professionals.
Recent Developments:
- In March 2024, Aidoc partnered with the American College of Radiology to launch a nationwide clinical AI deployment initiative aimed at enhancing stroke and pulmonary embolism detection.
- In January 2025, Vuno, Inc. received European CE certification for its AI-powered VUNO Med–Chest X-ray™ solution, enabling accelerated expansion across healthcare systems in the European Union.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Siemens Healthineers
- Zebra Technologies Corp.
- Riverain Technologies
- Vuno, Inc.
- Aidoc
- NovaSignal Corporation
- Imagen
- Digital Diagnostics, Inc.
- GE Healthcare
- AliveCor Inc.
- F. Hoffmann-La Roche Ltd
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY COMPONENT - MARKET ANALYSIS, 2019 - 2032
- Software
- Hardware
- Services
GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY DIAGNOSIS - MARKET ANALYSIS, 2019 - 2032
- Cardiology
- Oncology
- Pathology
- Radiology
- Chest and Lung
- Neurology
- Others
GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Artificial Intelligence in Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Artificial Intelligence in Diagnostics Market Snippet by Component
2.1.2. Artificial Intelligence in Diagnostics Market Snippet by Diagnosis
2.1.3. Artificial Intelligence in Diagnostics Market Snippet by Country
2.1.4. Artificial Intelligence in Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Artificial Intelligence in Diagnostics Key Market Trends
3.1. Artificial Intelligence in Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Artificial Intelligence in Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Artificial Intelligence in Diagnostics Market Opportunities
3.4. Artificial Intelligence in Diagnostics Market Future Trends
4. Artificial Intelligence in Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Artificial Intelligence in Diagnostics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Artificial Intelligence in Diagnostics Market Landscape
6.1. Artificial Intelligence in Diagnostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Artificial Intelligence in Diagnostics Market – By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
7.1.2. Software
7.1.3. Hardware
7.1.4. Services
8. Artificial Intelligence in Diagnostics Market – By Diagnosis
8.1. Overview
8.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
8.1.2. Cardiology
8.1.3. Oncology
8.1.4. Pathology
8.1.5. Radiology
8.1.6. Chest and Lung
8.1.7. Neurology
8.1.8. Others
9. Artificial Intelligence in Diagnostics Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
9.2.1. Overview
9.2.2. Artificial Intelligence in Diagnostics Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.2.5. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Artificial Intelligence in Diagnostics Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.7. France
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.7.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.7.4. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.8. Italy
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.8.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.8.4. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.9. Spain
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.9.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.9.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.10. United Kingdom
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.10.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.10.4. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.11. Russia
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.11.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.11.3. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.12. Netherlands
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.12.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.12.3. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.13. Sweden
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.13.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.13.3. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.14. Poland
9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.14.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.14.3. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.3.15. Rest of Europe
9.3.15.1. Overview
9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Artificial Intelligence in Diagnostics Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4.8. South Korea
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.8.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.8.4. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4.9. Japan
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.9.4. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Artificial Intelligence in Diagnostics Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Artificial Intelligence in Diagnostics Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
10. Key Vendor Analysis- Artificial Intelligence in Diagnostics Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Siemens Healthineers
10.2.2. Zebra Technologies Corp.
10.2.3. Riverain Technologies
10.2.4. Vuno, Inc.
10.2.5. Aidoc
10.2.6. NovaSignal Corporation
10.2.7. Imagen
10.2.8. Digital Diagnostics, Inc.
10.2.9. GE Healthcare
10.2.10. AliveCor Inc.
10.2.11. F. Hoffmann-La Roche Ltd
10.2.12. Others
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
